VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,791,475 | -19.6% | 66,573 | -10.0% | 0.00% | -33.3% |
| Q2 2023 | $2,227,834 | -39.1% | 73,990 | -34.6% | 0.00% | -40.0% |
| Q1 2023 | $3,657,368 | +57.6% | 113,056 | +39.6% | 0.01% | +66.7% |
| Q4 2022 | $2,321,260 | -19.1% | 80,993 | -32.0% | 0.00% | -40.0% |
| Q3 2022 | $2,871,000 | +54.4% | 119,048 | +75.3% | 0.01% | +66.7% |
| Q2 2022 | $1,860,000 | -23.6% | 67,917 | +7.0% | 0.00% | -25.0% |
| Q1 2022 | $2,433,000 | +29.5% | 63,445 | +8.1% | 0.00% | +33.3% |
| Q4 2021 | $1,879,000 | +45.5% | 58,667 | +33.9% | 0.00% | +50.0% |
| Q3 2021 | $1,291,000 | -45.8% | 43,819 | -37.4% | 0.00% | -50.0% |
| Q2 2021 | $2,380,000 | +5.6% | 70,046 | -2.4% | 0.00% | -20.0% |
| Q1 2021 | $2,254,000 | +8.9% | 71,770 | +22.8% | 0.01% | 0.0% |
| Q4 2020 | $2,069,000 | -12.5% | 58,444 | -4.7% | 0.01% | -16.7% |
| Q3 2020 | $2,365,000 | +70.0% | 61,336 | +61.7% | 0.01% | +50.0% |
| Q2 2020 | $1,391,000 | +124.0% | 37,933 | +40.8% | 0.00% | +100.0% |
| Q1 2020 | $621,000 | -41.3% | 26,947 | -31.8% | 0.00% | -33.3% |
| Q4 2019 | $1,058,000 | -41.4% | 39,485 | -42.4% | 0.00% | -50.0% |
| Q3 2019 | $1,804,000 | +61.1% | 68,580 | +53.2% | 0.01% | +50.0% |
| Q2 2019 | $1,120,000 | +21.3% | 44,757 | +6.2% | 0.00% | +33.3% |
| Q1 2019 | $923,000 | -5.5% | 42,146 | -12.6% | 0.00% | -25.0% |
| Q4 2018 | $977,000 | -10.3% | 48,215 | -18.0% | 0.00% | 0.0% |
| Q3 2018 | $1,089,000 | -16.7% | 58,812 | -7.8% | 0.00% | -20.0% |
| Q2 2018 | $1,308,000 | +9.0% | 63,786 | +16.8% | 0.01% | 0.0% |
| Q1 2018 | $1,200,000 | +15.1% | 54,613 | +21.7% | 0.01% | +25.0% |
| Q4 2017 | $1,043,000 | +62.7% | 44,891 | +60.9% | 0.00% | +33.3% |
| Q3 2017 | $641,000 | -39.8% | 27,902 | -42.2% | 0.00% | -40.0% |
| Q2 2017 | $1,065,000 | +21.0% | 48,244 | -0.2% | 0.01% | 0.0% |
| Q1 2017 | $880,000 | -54.2% | 48,339 | -49.7% | 0.01% | -58.3% |
| Q4 2016 | $1,920,000 | +105.6% | 96,047 | +139.4% | 0.01% | +100.0% |
| Q3 2016 | $934,000 | +50.2% | 40,124 | +72.8% | 0.01% | +50.0% |
| Q2 2016 | $622,000 | – | 23,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |